Cargando…

Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology

To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjerpe, Anders, Ascoli, Valeria, Bedrossian, Carlos, Boon, Mathilde, Creaney, Jenette, Davidson, Ben, Dejmek, Annika, Dobra, Katalin, Fassina, Ambrogio, Field, Andrew, Firat, Pinar, Kamei, Toshiaki, Kobayashi, Tadao, Michael, Claire W., Önder, Sevgen, Segal, Amanda, Vielh, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678521/
https://www.ncbi.nlm.nih.gov/pubmed/26681974
http://dx.doi.org/10.4103/1742-6413.170726
_version_ 1782405456958849024
author Hjerpe, Anders
Ascoli, Valeria
Bedrossian, Carlos
Boon, Mathilde
Creaney, Jenette
Davidson, Ben
Dejmek, Annika
Dobra, Katalin
Fassina, Ambrogio
Field, Andrew
Firat, Pinar
Kamei, Toshiaki
Kobayashi, Tadao
Michael, Claire W.
Önder, Sevgen
Segal, Amanda
Vielh, Philippe
author_facet Hjerpe, Anders
Ascoli, Valeria
Bedrossian, Carlos
Boon, Mathilde
Creaney, Jenette
Davidson, Ben
Dejmek, Annika
Dobra, Katalin
Fassina, Ambrogio
Field, Andrew
Firat, Pinar
Kamei, Toshiaki
Kobayashi, Tadao
Michael, Claire W.
Önder, Sevgen
Segal, Amanda
Vielh, Philippe
author_sort Hjerpe, Anders
collection PubMed
description To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference material includes peer-reviewed publications and textbooks. This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists, who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in cape town. During the previous IMIG biennial meetings, thorough discussions have resulted in published guidelines for the pathologic diagnosis of MM. However, previous recommendations have stated that the diagnosis of MM should be based on histological material only.[12] Accumulating evidence now indicates that the cytological diagnosis of MM supported by ancillary techniques is as reliable as that based on histopathology, although the sensitivity with cytology may be somewhat lower.[345] Recognizing that noninvasive diagnostic modalities benefit both the patient and the health system, future recommendations should include cytology as an accepted method for the diagnosis of this malignancy.[67] The article describes the consensus of opinions of the authors on how cytology together with ancillary testing can be used to establish a reliable diagnosis of MM.
format Online
Article
Text
id pubmed-4678521
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46785212015-12-17 Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology Hjerpe, Anders Ascoli, Valeria Bedrossian, Carlos Boon, Mathilde Creaney, Jenette Davidson, Ben Dejmek, Annika Dobra, Katalin Fassina, Ambrogio Field, Andrew Firat, Pinar Kamei, Toshiaki Kobayashi, Tadao Michael, Claire W. Önder, Sevgen Segal, Amanda Vielh, Philippe Cytojournal Review Article To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference material includes peer-reviewed publications and textbooks. This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists, who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in cape town. During the previous IMIG biennial meetings, thorough discussions have resulted in published guidelines for the pathologic diagnosis of MM. However, previous recommendations have stated that the diagnosis of MM should be based on histological material only.[12] Accumulating evidence now indicates that the cytological diagnosis of MM supported by ancillary techniques is as reliable as that based on histopathology, although the sensitivity with cytology may be somewhat lower.[345] Recognizing that noninvasive diagnostic modalities benefit both the patient and the health system, future recommendations should include cytology as an accepted method for the diagnosis of this malignancy.[67] The article describes the consensus of opinions of the authors on how cytology together with ancillary testing can be used to establish a reliable diagnosis of MM. Medknow Publications & Media Pvt Ltd 2015-11-30 /pmc/articles/PMC4678521/ /pubmed/26681974 http://dx.doi.org/10.4103/1742-6413.170726 Text en Copyright: © 2015 Hjerpe, et al.; Licensee Cytopathology Foundation Inc. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Hjerpe, Anders
Ascoli, Valeria
Bedrossian, Carlos
Boon, Mathilde
Creaney, Jenette
Davidson, Ben
Dejmek, Annika
Dobra, Katalin
Fassina, Ambrogio
Field, Andrew
Firat, Pinar
Kamei, Toshiaki
Kobayashi, Tadao
Michael, Claire W.
Önder, Sevgen
Segal, Amanda
Vielh, Philippe
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
title Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
title_full Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
title_fullStr Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
title_full_unstemmed Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
title_short Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
title_sort guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. complementary statement from the international mesothelioma interest group, also endorsed by the international academy of cytology and the papanicolaou society of cytopathology
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678521/
https://www.ncbi.nlm.nih.gov/pubmed/26681974
http://dx.doi.org/10.4103/1742-6413.170726
work_keys_str_mv AT hjerpeanders guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT ascolivaleria guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT bedrossiancarlos guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT boonmathilde guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT creaneyjenette guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT davidsonben guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT dejmekannika guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT dobrakatalin guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT fassinaambrogio guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT fieldandrew guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT firatpinar guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT kameitoshiaki guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT kobayashitadao guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT michaelclairew guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT ondersevgen guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT segalamanda guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology
AT vielhphilippe guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology